Characterization of the mouse lysosomal sialidase promoter

Gene

Volumn 319, Issue 1-2, 2003, Pages 177-187

  Champigny, Marc J ^a   Johnson, Matthew ^a   Igdoura, Suleiman A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Adenovirus; CDP; Footprint; MyoD; Regulation; Sialidosis; Sp 1; Tay Sachs

Indexed keywords

CCAAT DISPLACEMENT PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CIS ACTING ELEMENT; DEOXYRIBONUCLEASE; MYOD PROTEIN; MYOGENIC FACTOR 5; PROTEIN; REGULATOR PROTEIN; SIALIDASE; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DNA FOOTPRINTING; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; HUMAN; MOLECULAR GENETICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION SITE;

ADENOVIRIDAE; GENETTA;

EID: 0242352603     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(03)00808-4     Document Type: Article

References (37)

1. Andres V., Chiara M.D., Mahdavi V. A new bipartite DNA-binding domain: cooperative interaction between the cut repeat and homeo domain of the cut homeo proteins. Genes Dev. 8:1994;245-257.
2. Aufiero B., Neufeld E.J., Orkin S.H. Sequence-specific DNA binding of individual cut repeats of the human CCAAT displacement/cut homeodomain protein. Proc. Natl. Acad. Sci. USA. 91:1994;7757-7761.
3. Ausubel F.M. Current Protocols in Molecular Biology. 1998;Wiley, New York.
4. Blackwell T.K., Weintraub H. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science. 250:1990;1104-1110.
5. Bonten E.J., Arts W.F., Beck M., Covanis A., Donati M.A., Parini R., Zammarchi E., d'Azzo A. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Hum. Mol. Genet. 9:2000;2715-2725.
6. Carninci P., Shibata Y., Hayatsu N., Sugahara Y., Shibata K., Itoh M., Konno H., Okazaki Y., Muramatsu M., Hayashizaki Y. Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes. Genome Res. 10:2000;1617-1630.
7. a allele. Glycobiology. 7:1997;975-986.
8. Corfield T. Bacterial sialidases - roles in pathogenicity and nutrition. Glycobiology. 2:1992;509-521.
9. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 51:1987;987-1000.
10. Ferrari J., Harris R., Warner T.G. Cloning and expression of a soluble sialidase from Chinese hamster ovary cells: sequence alignment similarities to bacterial sialidases. Glycobiology. 4:1994;367-373.
11. M2 gangliosidoses. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;2839-2879 McGraw-Hill, New York, NY.
12. Harada R., Berube G., Tamplin O.J., Denis-Larose C., Nepveu A. DNA-binding specificity of the cut repeats from the human Cut-like protein. Mol. Cell. Biol. 15:1995;129-140.
13. Higgy N.A., Tarnasky H.A., Valarche I., Nepveu A., van der Hoorn F.A. Cux/CDP homeodomain protein binds to an enhancer in the rat c-mos locus and represses its activity. Biochim. Biophys. Acta. 1351:1997;313-324.
14. Igdoura S.A., Gafuik C., Mertineit C., Saberi F., Pshezhetsky A.V., Potier M., Trasler J.M., Gravel R.A. Cloning of the cDNA and gene encoding mouse lysosomal sialidase and correction of sialidase deficiency in human sialidosis and mouse SM/J fibroblasts. Hum. Mol. Genet. 7:1998;115-121.
15. Igdoura S.A., Mertineit C., Trasler J.M., Gravel R.A. Sialidase-mediated depletion of GM2 ganglioside in Tay-Sachs neuroglia cells. Hum. Mol. Genet. 8:1999;1111-1116.
16. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 50:1987;509-517.
17. Krag T.O.B., Gyrd-Hansen M., Khurana T.S. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy. Acta Physiol. Scand. 171:2001;349-358.
18. Lassar A.B., Buskin J.N., Lockshon D., Davis R.L., Apone S., Hauschka S.D., Weintraub H. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell. 58:1989;823-831.
19. Love D.R., Byth B.C., Tinsley J.M., Blake D.J., Davies K.E. Dystrophin and dystrophin-related proteins: a review of protein and RNA studies. Neuromuscul. Disord. 3:1993;5-21.
20. Miyagi T., Wada T., Iwamatsu A., Hata K., Yoshikawa Y., Tokuyama S., Sawada M. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J. Biol. Chem. 274:1999;5004-5011.
21. Monti E., Preti A., Rossi E., Ballabio A., Borsani G. Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases. Genomics. 57:1999;137-143.
22. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene. 270:2001;1-15.
23. Ng P., Parks R.J., Cummings D.T., Evelegh C.M., Graham F.L. An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. Hum. Gene Ther. 11:2000;693-699.
24. O'Brien J.S., Warner T.G. Sialidosis: delineation of subtypes by neuraminidase assay. Clin. Genet. 17:1980;35-38.
25. Olivieri N.F., Weatherall D.J. The therapeutic reactivation of fetal haemoglobin. Hum. Mol. Genet. 7:1998;1655-1658.
26. Phaneuf D., Wakamatsu N., Huang J.-Q., Borowski A., Peterson A.C., Fortunato S.R., Ritter G., Igdoura S.A., Morales C.R., Benoit G., Akerman B.R., Leclerc D., Hanai N., Marth J.D., Trasler J.M., Gravel R.A. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 5:1996;1-14.
27. Pshezhetsky A.V., Richard C., Michaud L., Igdoura S., Wang S., Elslinger M., Ou J., Leclerc D., Gravel R., Dallaire L., Potier M. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat. Genet. 15:1997;316-320.
28. Reuter G., Gabius H.-J. Sialic acids: structure, analysis, metabolism, occurrence, recognition. Biol. Chem. Hoppe-Seyler. 377:1996;325-342.
29. Rudnicki M.A., Jaenisch R. The MyoD family of transcription factors and skeletal myogenesis. BioEssays. 17:1995;203-209.
30. Saito M., Yu R.K. Rosenberg A. Biology of the Sialic Acids. 1995;261-313 Plenum, New York, NY.
31. Sandhoff K., Kolter T. Biochemistry of glycosphingolipid degradation. Clin. Chim. Acta. 266:1997;51-61.
32. Sandhoff K., Harzer K., Wassle W., Jatzkewitz H. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J. Neurochem. 18:1971;2469-2489.
33. Sandhoff K., Kolter T., Van Echten-Deckert G. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell. Ann. NY Acad. Sci. 845:1998;139-151.
34. Sango K., Yamanaka S., Hoffmann A., Okuda Y., Grinberg A., Westphal H., McDonald M.P., Crawley J.N., Sandhoff K., Suzuki K., Proia R.L. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat. Genet. 14:1996;348-352.
35. Sasagasako N., Miyahara S., Saito N., Shinnoh N., Kobayashi T., Goto I. Prenatal diagnosis of congenital sialidosis. Clin. Genet. 44:1993;8-11.
36. Tinsley J.M., Potter A.C., Phelps S.R., Fisher R., Trickett J.I., Davies K.E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature. 384:1996;349-353.
37. Wada T., Yoshikawa Y., Tokuyama S., Kuwabara M., Akita H., Miyagi T. Cloning, expression, and chromosomal mapping of a human ganglioside sialidase. Biochem. Biophys. Res. Commun. 261:1999;21-27.